Filter
1911
Filtered Results: 1911
Text search:
molecular
Featured
Recommendations
224
New Publications
349
Language
Document type
No document type
835
Guidelines
440
Studies & Reports
330
Manuals
112
Strategic & Response Plan
79
Fact sheets
53
Training Material
23
Situation Updates
17
Infographics
10
Resource Platforms
9
Videos
2
Brochures
1
Countries / Regions
India
95
Latin America and the Carribbean
72
Global
64
Brazil
62
Western and Central Europe
61
Africa
43
Eastern Europe
36
Germany
34
Kenya
30
Colombia
30
South Africa
28
Argentina
25
Senegal
23
Ethiopia
22
Tanzania
22
Peru
22
West and Central Africa
22
Venezuela
20
East and Southern Africa
19
Russia
18
Congo, Democratic Republic of
17
El Salvador
17
Mozambique
16
Paraguay
15
Uganda
14
Rwanda
14
South–East Asia Region
14
Sierra Leone
13
Bolivia
13
Nigeria
12
Malawi
12
Philippines
11
Nepal
10
Angola
10
Chile
10
Asia
10
Cameroon
9
Zambia
9
Ukraine
9
Ecuador
9
Burkina Faso
8
Liberia
8
Indonesia
8
Middle East and North Africa
8
Ghana
7
Haiti
7
Bangladesh
7
Namibia
7
Spain
7
Zimbabwe
6
Syria
6
Guinea
5
Benin
5
Myanmar / Burma
5
Western Pacific Region
5
Eastern Europe and Central Asia
5
France
5
Mali
4
Guinea-Bissau
4
Côte d’Ivoire / Ivory Coast
4
USA
4
Pakistan
4
Madagascar
4
Italy
4
Vietnam
4
Niger
3
Lebanon
3
Chad
3
Cambodia
3
Eswatini/ Swaziland
3
Botswana
3
Uruguay
3
Morocco
2
Saudi Arabia
2
Togo
2
Somalia
2
South Sudan
2
Iraq
2
Jordan
2
Turkey
2
Thailand
2
China
2
Mauritania
2
Dominican Republic
2
Honduras
2
Libya
2
Guatemala
2
Congo-Brazzaville
2
Tajikistan
2
Georgia
2
North America
2
United Kingdom
2
Portugal
2
Afghanistan
1
Egypt
1
Gambia
1
Malaysia
1
Sudan
1
Central African Republic
1
North Macedonia
1
Switzerland
1
Cuba
1
Burundi
1
Lesotho
1
Mexico
1
Nicaragua
1
Yemen
1
Luxembourg
1
Palestine
1
Djibouti
1
Canada
1
Timor Leste/ East Timor
1
Qatar
1
Estonia
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Japan
1
Belgium
1
Tunisia
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
663
Clinical Guidelines
247
Public Health
82
Pharmacy & Technologies
68
Key Resources
31
Women & Child Health
25
Capacity Building
6
Toolboxes
TB
411
COVID-19
305
AMR
117
NTDs
116
Rapid Response
88
HIV
88
Mental Health
81
Ebola
57
Planetary Health
47
Zika
35
Pharmacy
33
NCDs
27
Refugee
24
Caregiver
18
Polio
16
Specific Hazards
11
Cholera
10
Global Health Education
9
Disability
8
Health Financing Toolbox
6
Conflict
5
Natural Hazards
4
Anopheles stephensi, a highly competent vector of Plasmodium falciparum and P. vivax, is considered an efficient vector of urban malaria. Until 2011, the reported distribution of An. stephensi was confined to certain countries of South Asia and parts of the Arabian Peninsula. Since then, the vector ...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Mycetoma is a chronic infectious disease of the subcutaneous tissue with a high morbidity. This disease has been reported from countries between 30°N and 15°S since 1840 but the exact burden of disease is not known. It is currently unknown what the incidence, prevalence and the number of reported ...
Snakebite envenoming is a serious public health problem in Central America, where approximately 5,500 cases occur every year. Panama has the highest incidence and El Salvador the lowest. The majority, and most severe, cases are inflicted by the pit viper Bothrops asper (family Viperidae), locally kn...
Human African trypanosomiasis (HAT), or sleeping sickness, is an endemic disease in 36 sub-Saharan African countries, typically occurring in underdeveloped areas, where
health systems face significant difficulties of diverse natures.
The WHO standard: Universal access to rapid tuberculosis diagnostics sets benchmarks to achieve universal access to WHO-recommended rapid diagnostics (WRDs), increase bacteriologically confirmed tuberculosis and drug resistance detection, and reduce the time to diagnosis. WHO-recommended rapid diagn...
The Africa Centres for Disease Control and Prevention (Africa CDC) Biosafety and Biosecurity Initiative was launched by the Africa CDC in April 2019 with the aim of strengthening the African Union (AU) Member States’ biosafety and biosecurity systems and enabling them to comply with national and i...
This publication aims to provide updated guidance on the specific use of yellow fever laboratory assays in the context of surveillance to be used across the Global Yellow Fever Laboratory Network for disease surveillance. In the recent years, new commercial assays became available and are now recomm...
Laboratory manual for yellow fever
recommended
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular disease and common measures of socioeconomic status—wealth and education—differ among...
Public health emergencies, including pandemics, highlight the need for health systems and services that are prepared, resilient and ready to respond to health security threats. Endorsed by Member States in 2023, the Asia Pacific Health Security Action Framework (APHSAF) is designed to engage m...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that the goal of asthma treatment should be to achieve and maintain control of the...
Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on
dolutegravir-based antiretroviral therapy (November 2020– September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 ...
El reciente aumento de los casos de microcefalia y de otros trastornos neurológicos posiblemente asociados a la infección por el virus de Zika ha provocado un aumento de la demanda de pruebas de laboratorio para detectar dicha infección. Los grupos prioritarios para la realización de pruebas di...
O recente aumento dos casos de microcefalia e outras patologias neurológicas potencialmente associadas à infecção pelo vírus Zika provocou um aumento da procura de testes laboratoriais para detectar a infecção. Os grupos prioritários para os testes de diagnóstico devem ser
indivíduos sin...
